HALISTER: Novartis Says David Epstein to Leave; Splits Pharma Unit in Two

Novartis Says David Epstein to Leave; Splits Pharma Unit in Two

(Bloomberg) -- Co. says will split its pharma business into two business units, Novartis Pharmaceuticals and Novartis Oncology.
  • Says Paul Hudson appointed CEO of Novartis Pharmaceuticals and Bruno Strigini appointed CEO of Novartis Oncology; David Epstein, head of pharma, to leave Novartis
  • Novartis Pharmaceuticals and Novartis Oncology will form the Innovative Medicines Division at Novartis
Link to Statement:Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
NOVN VX (Novartis AG)

People
David Epstein (Novartis AG)
Paul Hudson (AstraZeneca KK)

Topics
First Word DC - Foreign Policy
Management Changes
Who's News - People

To de-activate this alert, click here

UUID: 7947283